Startup pitching app as money-saver for hospitals
The founder and CEO of Diagnotes Inc. thinks his company’s mobile app can help doctors run their office from their iPhones—just as many other professionals have been doing for years.
The founder and CEO of Diagnotes Inc. thinks his company’s mobile app can help doctors run their office from their iPhones—just as many other professionals have been doing for years.
Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug.
Drug companies like Eli Lilly and Co. can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.
Eli Lilly and Co. will pay Canadian drug developer Transition Therapeutics Inc. at least $7 million and up to as much as $247 million to take over the development of a potential diabetes treatment.
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a statement.
Carmel-based Mainstreet Property Group has built 13 nursing homes in Indiana and Illinois since 2008. Six of the dozen Indiana properties benefited from municipal-backed credit or tax breaks, and a seventh received a reduced-impact fee. Mainstreet also received $345,000 in state economic incentives.
Starting July 1, pharmacists will be able to offer a much wider variety of immunizations to customers, in an effort from lawmakers to make health care more accessible.
After overseeing 15 years of massive growth via mergers, Vince Caponi will become an executive of St. Vincent Health’s parent organization.
The new not-for-profit organization is expected to be named Planned Parenthood of Indiana and Kentucky—or PPINK—and continue to operate the 28 existing health centers between the two states.
US HealthWorks Medical Group, which specializes in workers’ compensation cases, agreed in May to acquire the eight clinics. The deal is expected to close before the end of June.
The not-for-profit blood center announced Monday that demand from hospitals has fallen 24 percent over the past year, forcing it to take steps that also include freezing management salaries, eliminating 45 positions and discontinuing a therapeutic phlebotomy program.
Patients who got Erbitux together with chemotherapy as a first-line treatment lived about four months longer than those who got Avastin with chemotherapy, according to the 592-person study.
The 65,000-square-foot nursing-home and assisted-living facility would feature an Internet cafe, movie theaters and restaurant-style dining with an on-site chef.
Indianapolis-area hospitals are undergoing such profound and permanent changes that some predict, eventually the four major hospital systems will merge and shrink down to two.
The Supreme Court will not disturb a lower court ruling that blocks Indiana's effort to strip Medicaid funds from Planned Parenthood because the organization performs abortions.
The study results, which will be released Monday afternoon, are part of Indianapolis-based Lilly’s campaign to get Medicare to pay for use of its brain imaging agent Amyvid.
Eli Lilly claims recent decisions by Canadian courts invalidating 17 drug patents have made the country an outlier among major developed countries.
Eli Lilly and Co. CEO John Lechleiter underwent a scheduled surgery Monday for a heart defect, and the repair to the aorta is functioning as intended, the Indianapolis-based drugmaker said.
Dr. Jay Hess was picked to become the 10th dean in the school of medicine’s 110-year history and the first dean in the past five to come from outside IU.
Rather than raising prices on private health insurers to make up for inadequate payments from the government, hospitals across the country have been raising prices just because they can, according to a new study.